The abstract is read at the publisher; the summary is JClub's.
ERS guidelines for patients with idiopathic pulmonary fibrosis and lung cancer issue 11 conditional recommendations, including surgery for early-stage disease and avoiding concurrent radio-chemotherapy in locally advanced cases.
- Why it matters: Concomitant IPF and lung cancer poses major management challenges because treatment can worsen lung outcomes, yet evidence-based guidance is limited for balancing cancer benefit against toxicity.
- What they did: An ERS multidisciplinary Task Force with patient representatives developed 11 conditional recommendations across seven PICO questions and two narrative questions, using systematic reviews and GRADE plus Evidence-to-Decision.
- The result: Recommendations suggest surgical resection for medically fit early-stage patients with careful preoperative evaluation and perioperative antifibrotic discussion, conditional stereotactic radiotherapy options, no concurrent radio-chemotherapy in locally advanced disease, chemotherapy for advanced-stage medically fit patients, and conditional immunotherapy options for stage IV.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.